Biogen is a biotechnology company founded in 1978, specializing in the development of therapies for neurological diseases. It is known for its innovative treatments for conditions such as multiple sclerosis and amyotrophic lateral sclerosis (ALS). The company focuses on research and development to address unmet medical needs in the field of neuroscience. Headquartered in Cambridge, Massachusetts, Biogen operates globally and collaborates with various research institutions and organizations. Its commitment to advancing science has led to significant contributions in the treatment of Alzheimer's disease and other neurodegenerative disorders, making it a key player in the biotechnology industry.